Уноси

• Пројекат-Повезаност полиморфизама гена значајних за метаболизам масти и угљених хидрата са липидним параметрима код пацијената са акутним инфарктом миокарда (2024-01)

  S. Vidović, R. Škrbić, V. Vidovic, I. Milovac, N. Maksimović, Ž. Radić Savić, N. Malešević, J. Bećarević, Пројекат-Повезаност полиморфизама гена значајних за метаболизам масти и угљених хидрата са липидним параметрима код пацијената са акутним инфарктом миокарда, МИНИСТАРСТВО ЗА НАУЧНОТЕХНОЛОШКИ РАЗВОЈ И ВИСОКО ОБРАЗОВАЊЕ РЕПУБЛИКЕ СРПСКЕ, Jan, 2024

• Dijagnostičko - terapijski vodić za porodičnu medicinu: Srčana insuficijencija (2007)

  D. Vulić, D. Kuprešak, M. Krneta, R. Škrbić, G. Tešanović, N. Putnik, V. Petrović, B. Goronja, Dijagnostičko - terapijski vodić za porodičnu medicinu: Srčana insuficijencija, pp. 1 - 12, Udruženje doktora porodične medicine Republike Srpske, Udruženje kardiologa Republike Srpske, Banja Luka, 2007

• Polyphenolic content, antioxidative and antimicrobial activity of Eryngium amethystinum L. methanolic extracts (2025-01)

  Mladen Duran, LJiljana Božić, Aleksandra Šmitran, Milica Gajić Bojić, Relja Suručić, Ranko Škrbić, Polyphenolic content, antioxidative and antimicrobial activity of Eryngium amethystinum L. methanolic extracts, Jan, 2025

• Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial (2025-01)

  Jelena Petković-Dabić, Ivana Binić, Bojana Carić, Ljiljana Božić, Sanja Umičević-Šipka, Nataša Bednarčuk, Saša Dabić, Mirna Šitum, Snježana Popović-Pejičić, Miloš P. Stojiljković, Ranko Škrbić, Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial, Biomolecules, Jan, 2025

• Cardioprotective effects of liraglutide pretreatment on isoprenaline-induced myocardial injury in rats (2023)

  Zorislava Bajic, Tanja Sobot, Snezana Uletilovic, Nebojsa Mandic-Kovacevic, Tanja Cvjetkovic, Ugljesa Malicevic, Djordje Djukanovic, Mladen Duran, Nikolina Vesic, Sanja Avram, Sanja Jovicic, Maja Katana, Amela Matavulj, Nenad Ponorac, Dragan M Djuric, Milos Stojiljkovic, Ranko Skrbic, Cardioprotective effects of liraglutide pretreatment on isoprenaline-induced myocardial injury in rats, CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, Vol. 00, pp. 1 - 10, 2023

• Seroprevalence of SARS-CoV-2 antibodies among primary healthcare workers in the Republic of Srpska, Bosnia & Herzegovina: a cross-sectional study (2022-03)

  Darija Knežević, Miroslav Petković, Ljiljana Božić, Nataša Miljuš, Biljana Mijović, Jela Aćimović, Jelena Djaković Dević, Dragana Puhalo Sladoje, Srđan Mašić, Dragan Spaić, Nevena Todorović, Nataša Pilipović-Broćeta, Verica Petrović, Dejan Bokonjić, Miloš P. Stojiljković, Ranko Škrbić, Seroprevalence of SARS-CoV-2 antibodies among primary healthcare workers in the Republic of Srpska, Bosnia & Herzegovina: a cross-sectional study, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, Vol. 69, No. 1, pp. 18 - 26, Mar, 2022

• Experimental models of myocardial injury: is there possibility of cardioprotection induced by homocysteine-related vitamins? (2023-07)

  Djurić DM, Jakovljevic Uzelac J, Mutavdzin Krneta S, Todorovic D, Stojanovic M, Stankovic S, Sobot T, Bajic Z, Stojiljkovic MP, Skrbic R., Experimental models of myocardial injury: is there possibility of cardioprotection induced by homocysteine-related vitamins?, Abstract Book, pp. 32 - 33, Jul, 2023

• Isoprenaline model as stress induced myocardial injury. (2024-09)

  Bajić Z, Šobot T, Đurić DM, Stojiljković MP, Škrbić R., Isoprenaline model as stress induced myocardial injury., Acta Physiol (Oxf); 240 Suppl 731:e14224., Sep, 2024

• Cholinergic mechanisms and isoprenaline-induced heart failure in rats. (2024-10)

  Stojiljković MP, Škrbić R, Marinković S, Maksimović ŽM, Šobot T, Bajić Z et al., Cholinergic mechanisms and isoprenaline-induced heart failure in rats., Abstract Collection in Eur Pharm J., Oct, 2024

• Isoprenaline model of chronic heart failure – comparison of the time-dependent functional and structural changes of the myocardium. (2024-10)

  Marinković S, Maksimović ŽM, Šobot T, Đukanović Đ, Jovičić S, Škrbić R, et al., Isoprenaline model of chronic heart failure – comparison of the time-dependent functional and structural changes of the myocardium., Abstract Collection in Eur Pharm J., Oct, 2024

• Pyridostigmine treatment significantly alleviates isoprenaline-induced chronic heart failure in rats. (2025-11)

  Stojiljkovic MP, Skrbic R, Marinkovic ST, Sobot T, Maksimovic ZM, Dukanovic D, et al., Pyridostigmine treatment significantly alleviates isoprenaline-induced chronic heart failure in rats., Cor Vasa. 2025;67(Suppl 4)., Nov, 2025

• The effect of pyridostigmine treatment on two isoprenaline models of heart failure in rats. (2026)

  Stojiljković MP, Marinković S, Šobot T, Maksimović ŽM, Bajić Z, Đukanović Đ, Uletilović S, Mandić-Kovačević N, Jovičić S, Matičić M, Gajić Bojić M, Stojmenovski A, Bojanić A, Lončar-Stojiljković D, Đurić DM, Škrbić R., The effect of pyridostigmine treatment on two isoprenaline models of heart failure in rats., Abstract Book, 2026

• High-Sensitivity Troponins and Homocysteine: Combined Biomarkers for Better Prediction of Cardiovascular Events (2025-08)

  Djuric D, Bajic Z, Radisavljevic N, Sobot T, Mutavdzin Krneta S, Stankovic S, Skrbic R., High-Sensitivity Troponins and Homocysteine: Combined Biomarkers for Better Prediction of Cardiovascular Events, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Vol. 26, No. 17, Aug, 2025

• Ursodeoxycholic Acid Attenuates Lipopolysaccharide-Induced Myocardial Injury by Inhibiting Oxidative Stress, Inflammation, and Apoptosis: The Interplay of Sirt1/Nrf2 and Akt/NF-κB Signaling Pathways. (2026-03)

  Škrbić R, Milivojac T, Bajic Z, Sobot T, Uletilović S, Jovičić S, Đukanović Đ, Gajić Bojić M, Barudžija M, Vojinović N, Stojiljković MP, Djuric DM, Al-Salami H, Bolevich S, Mikov M., Ursodeoxycholic Acid Attenuates Lipopolysaccharide-Induced Myocardial Injury by Inhibiting Oxidative Stress, Inflammation, and Apoptosis: The Interplay of Sirt1/Nrf2 and Akt/NF-κB Signaling Pathways., INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Vol. 27, No. 6, Mar, 2026

• Liraglutide treatment restores cardiac function after isoprenaline-induced myocardial injury and prevents heart failure in rats (2025-03)

  Bajic Z, Sobot T, Smitran A, Uletilovic S, Mandić-Kovačević N, Cvjetkovic T, Malicevic U, Stanetic B, Đukanović Đ, Maticic M, Jovicic S, Djuric D, Stojiljković M, Skrbic R., Liraglutide treatment restores cardiac function after isoprenaline-induced myocardial injury and prevents heart failure in rats, Life , Vol. 15, No. 3, Mar, 2025

• The Second Round of a Population-Based Seroprevalence Study of Anti–SARS-CoV-2 Antibodies and COVID-19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina (2026-01)

  J. Aćimović, B. Mijović, S. Mašić, M. Petković, D. Puhalo Sladoje, D. Knežević, J. Đaković Dević, D. Spaić, J. Vladičić Mašić, D. Bokonjić, M. Palo, A. Vaughan, R. Pebody, A. Nordone, R. Škrbić, The Second Round of a Population-Based Seroprevalence Study of Anti–SARS-CoV-2 Antibodies and COVID-19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina, INFLUENZA AND OTHER RESPIRATORY VIRUSES, Vol. 19, No. e70053, Jan, 2026

• Evaluation of chenodeoxycholic acid as a cardioprotective agent in isoprenaline-induced myocardial injury. (2025-11)

  Dukanovic D, Mihajlovic D, Maksimovic ZM, Marinkovic S, Malicevic U, Uletilovic S, Mandic-Kovacevic N, Јоvicic S, Bajic Z, Sobot T, Mikov M, Skrbic R., Evaluation of chenodeoxycholic acid as a cardioprotective agent in isoprenaline-induced myocardial injury., Cor Vasa. 2025;67(Suppl 4)., pp. 24 - 25, Nov, 2025

• LEVOSIMENDAN PRETREATMENT PRESERVES INTESTINAL TISSUE DAMAGE AND MULTI-ORGAN INJURY BY ATTENUATING OXIDATIVE STRESS, INFLAMMATION AND APOPTOSIS INDUCED BY MESENTERIC ARTERY ISCHEMIA AND REPERFUSION (2025-11)

  R. Skrbic, Z. Matkovic, M. Gajic Bojic, U. Malicevic, N. Mandic-Kovacevic, S. Uletilovic, LJ. Amidzic, S. Jovicic, M. Barudzija, M. Stojiljkovic, LEVOSIMENDAN PRETREATMENT PRESERVES INTESTINAL TISSUE DAMAGE AND MULTI-ORGAN INJURY BY ATTENUATING OXIDATIVE STRESS, INFLAMMATION AND APOPTOSIS INDUCED BY MESENTERIC ARTERY ISCHEMIA AND REPERFUSION, Nov, 2025

• Hyperglycemia impairs the expression of inflammatory mediators in rat intestine: an implication for intestinal inflammation and inflammatory bowel disease (2026-01)

  U. Maličević, V. Rai, R. Škrbić, D. Agrawal, Hyperglycemia impairs the expression of inflammatory mediators in rat intestine: an implication for intestinal inflammation and inflammatory bowel disease, MOLECULAR AND CELLULAR BIOCHEMISTRY, Jan, 2026

• Hydrogel Versus Alternative Vehicles for (Trans)dermal Delivery of Propranolol Hydrochloride—In Vitro and Ex Vivo Studies (2026)

  N. Bubić Pajić, M. Kaurin, A. Klepić, D. Knežević Ratković, A. Stojmenovski, V. Krstonošić, R. Škrbić, Hydrogel Versus Alternative Vehicles for (Trans)dermal Delivery of Propranolol Hydrochloride—In Vitro and Ex Vivo Studies, Gels, Vol. 12, No. 1, 2026